---
figid: PMC6144451__ACN3-5-1089-g007
figtitle: The effects of CLN3, flupirtine, retigabine, and benzyl (compound 5) or
  allyl (compound 6) carbamate derivatives on ceramide synthesis and intrinsic/extrinsic
  apoptotic pathways
organisms:
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Equus caballus
- Homo sapiens
- Gallus gallus
pmcid: PMC6144451
filename: ACN3-5-1089-g007.jpg
figlink: /pmc/articles/PMC6144451/figure/acn3625-fig-0007/
number: F7
caption: 'Schematic representation of the effects of CLN3, flupirtine, retigabine,
  and benzyl (compound 5) or allyl (compound 6) carbamate derivatives on ceramide
  synthesis and intrinsic/extrinsic apoptotic pathways. Schematic representation of
  sphingolipid synthetic pathways and apoptotic events. The sites of action of the
  various sphingolipid synthesis enzymes and the location of the CLN3 action are indicated.
  Enzymes downregulated are shown in pink. Apoptosis extrinsic and intrinsic pathways
  are indicated. Each requires specific triggering signals to begin an energy‐dependent
  cascade of molecular events. Each pathway activates its own initiator caspase (caspase
  8 or 9), which in turn activates executioner caspase 3. The execution pathway results
  in cell shrinkage, chromatin condensation, formation of cytoplasmic blebs and apoptotic
  bodies and ultimate phagocytosis of apoptotic bodies by adjacent parenchymal cells,
  neoplastic cells, or macrophages. Arrows indicate activation. Red T bar indicates
  inhibition. CLN3: Ceroid Lipofuscinosis, Neuronal 3; CERS2: Ceramide Synthase 2;
  CERS6: Ceramide Synthase 6; DEGS2: Delta 4‐Desaturase, Sphingolipid 2; SMPD1: Sphingomyelin
  Phosphodiesterase 1. FADD: FAS‐associated death domain; BAK: Bcl‐2 antagonist/killer‐1;
  BAX: BCL‐2‐associated X protein; BCL‐2: B‐cell lymphoma 2.'
papertitle: Flupirtine derivatives as potential treatment for the neuronal ceroid
  lipofuscinoses.
reftext: Joelle Makoukji, et al. Ann Clin Transl Neurol. 2018 Sep;5(9):1089-1103.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9517329
figid_alias: PMC6144451__F7
figtype: Figure
organisms_ner:
- Bos taurus
- Equus caballus
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Gallus gallus
redirect_from: /figures/PMC6144451__F7
ndex: c5d96e4e-ded6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6144451__ACN3-5-1089-g007.html
  '@type': Dataset
  description: 'Schematic representation of the effects of CLN3, flupirtine, retigabine,
    and benzyl (compound 5) or allyl (compound 6) carbamate derivatives on ceramide
    synthesis and intrinsic/extrinsic apoptotic pathways. Schematic representation
    of sphingolipid synthetic pathways and apoptotic events. The sites of action of
    the various sphingolipid synthesis enzymes and the location of the CLN3 action
    are indicated. Enzymes downregulated are shown in pink. Apoptosis extrinsic and
    intrinsic pathways are indicated. Each requires specific triggering signals to
    begin an energy‐dependent cascade of molecular events. Each pathway activates
    its own initiator caspase (caspase 8 or 9), which in turn activates executioner
    caspase 3. The execution pathway results in cell shrinkage, chromatin condensation,
    formation of cytoplasmic blebs and apoptotic bodies and ultimate phagocytosis
    of apoptotic bodies by adjacent parenchymal cells, neoplastic cells, or macrophages.
    Arrows indicate activation. Red T bar indicates inhibition. CLN3: Ceroid Lipofuscinosis,
    Neuronal 3; CERS2: Ceramide Synthase 2; CERS6: Ceramide Synthase 6; DEGS2: Delta
    4‐Desaturase, Sphingolipid 2; SMPD1: Sphingomyelin Phosphodiesterase 1. FADD:
    FAS‐associated death domain; BAK: Bcl‐2 antagonist/killer‐1; BAX: BCL‐2‐associated
    X protein; BCL‐2: B‐cell lymphoma 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FAS
  - FADD
  - BAX
  - CERS2
  - CERS6
  - CLN3
  - DEGS2
  - SMPD1
  - BCL2
  - Fas
  - Fasn
  - Fadd
  - Bax
  - Nkx3-1
  - Bak1
  - Casp9
  - Cers2
  - Cers6
  - Cln3
  - Degs2
  - Casp3
  - Smpd1
  - Bcl2
  - FASN
  - BAK1
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - Flupirtine
  - Retigabine
  - Carbamate
  - ceramide
  - Serine
  - Palmitoyl
  - Sphinganine
  - Ceramide
  - Dihydroceramide
  - Sphingomyelin Sphingosine
---
